Organic compounds -- part of the class 532-570 series – Organic compounds – Esters having the thiocarboxylate group – -cx- – wherein the...
Reexamination Certificate
2005-03-08
2005-03-08
Kumar, Shailendra (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Esters having the thiocarboxylate group, -cx-, wherein the...
C558S256000, C564S154000, C514S513000, C514S516000
Reexamination Certificate
active
06864383
ABSTRACT:
This invention relates to the use of potent potassium channel blockers or a formulation thereof in the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also relates to the use of such compounds to provide a neuroprotective effect to the eye of mammalian species, particularly humans.
REFERENCES:
patent: 5994293 (1999-11-01), Baxter et al.
patent: 6239305 (2001-05-01), Suzuki et al.
Gao Ying-Duo
Garcia Maria L.
Kaczorowski Gregory J.
Ayler Sylvia A.
Camara Valerie J.
Kumar Shailendra
Merck & Co. , Inc.
LandOfFree
Ophthalmic compositions for treating ocular hypertension does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ophthalmic compositions for treating ocular hypertension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic compositions for treating ocular hypertension will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3378825